139 related articles for article (PubMed ID: 38438110)
1. Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection.
Grinberg N; Whitefield S; Kleinman S; Frenkel G; Peleg O
J Oral Maxillofac Surg; 2024 May; 82(5):525-530. PubMed ID: 38438110
[TBL] [Abstract][Full Text] [Related]
2. Treating severe bruxism with botulinum toxin.
Tan EK; Jankovic J
J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin Injection for Chronic Parotitis: A Multi-Center and Prospective Trial.
Kwon SY; Chun KJ; Kil HK; Oh KH; Kim C; Jang SJ; Kim MS
Laryngoscope; 2021 Jun; 131(6):E1903-E1909. PubMed ID: 33111982
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
Baker JS; Nolan PJ
J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
[TBL] [Abstract][Full Text] [Related]
6. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
7. Changes in masticatory function after injection of botulinum toxin type A to masticatory muscles.
Park HU; Kim BI; Kang SM; Kim ST; Choi JH; Ahn HJ
J Oral Rehabil; 2013 Dec; 40(12):916-22. PubMed ID: 24237358
[TBL] [Abstract][Full Text] [Related]
8. Nonsurgical reshaping of the lower face.
Liew S; Dart A
Aesthet Surg J; 2008; 28(3):251-7. PubMed ID: 19083534
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical masseteric bulging after botulinum neurotoxin type A injection.
Sandhu S; Shaefer J
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514
[TBL] [Abstract][Full Text] [Related]
10. Acute visual loss after botulinum toxin A injection in the masseter muscle.
Chun BY; Kim SY
Int Ophthalmol; 2018 Jun; 38(3):1339-1342. PubMed ID: 28536763
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin in the treatment of bruxism: Systematic review.
Fernández-Núñez T; Amghar-Maach S; Gay-Escoda C
Med Oral Patol Oral Cir Bucal; 2019 Jul; 24(4):e416-e424. PubMed ID: 31246937
[TBL] [Abstract][Full Text] [Related]
12. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review.
De la Torre Canales G; Câmara-Souza MB; do Amaral CF; Garcia RC; Manfredini D
Clin Oral Investig; 2017 Apr; 21(3):727-734. PubMed ID: 28255752
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injection for bruxism associated with brain injury: case report.
Kesikburun S; Alaca R; Aras B; Tuğcu I; Tan AK
J Rehabil Res Dev; 2014; 51(4):661-4. PubMed ID: 25144179
[TBL] [Abstract][Full Text] [Related]
14. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of severe bruxism with botulinum toxin type A].
Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A in the management of masseter muscle hypertrophy.
Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
[TBL] [Abstract][Full Text] [Related]
19. Bruxism after brain injury: successful treatment with botulinum toxin-A.
Ivanhoe CB; Lai JM; Francisco GE
Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
[TBL] [Abstract][Full Text] [Related]
20. Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.
Song JH; Cho ES; Kim ST; Ahn HJ
Yonsei Med J; 2014 Jul; 55(4):1123-9. PubMed ID: 24954346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
